Jackson Creek Investment Advisors »

Tg Therapeutics shares owned by Jackson Creek Investment Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Jackson Creek Investment Advisors from 13F filings

Historical chart of Jackson Creek Investment Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Jackson Creek Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Jackson Creek Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $904k 59k 15.21

More positions owned by Jackson Creek Investment Advisors

Microsoft Corporation (MSFT)
Schwab Strategic Tr us reit etf (SCHH)
Sch Us Mid-cap Etf etf (SCHM)
Schwab Strategic Tr us lrg cap etf (SCHX)
Schwab Strategic Tr sht tm us tres (SCHO)
Schwab International Equity ETF (SCHF)
Vanguard Short-Term Bond ETF (BSV)
Schwab Emerging Markets Equity ETF (SCHE)
Schwab U S Small Cap ETF (SCHA)
Mr Cooper Group (COOP)
Gms (GMS)
Pubmatic Ord (PUBM)
Sprouts Fmrs Mkt (SFM)
Acm Research (ACMR)
Ishares 0-3 Month Treasury Bd Etf (SGOV)

View all positions for Jackson Creek Investment Advisors

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
Millennium Management
Pictet Asset Management Holding SA
Soleus Capital Management
Wellington Management Company
Geode Capital Management
Susquehanna International
Citadel Advisors
Opaleye Management
Bank of America Corporation
Sofinnova Ventures
683 Capital Management
Nuveen Asset Management
Woodline Partners

View all funds holding Tg Therapeutics